Biosig Technologies Inc BSGM

NAS: BSGM | ISIN: US09073N2018   30/04/2025
1,030 USD (+11,94%)
(+11,94%)   30/04/2025

19 maart 2021 · BioSig CEO Kenneth L. Londoner to Present at the Benzinga Biotech Small Cap Conference · Persbericht

10 maart 2021 · BioSig CEO Kenneth L. Londoner to Present at the Oppenheimer 31st Annual Healthcare Conference · Persbericht

9 maart 2021 · BioSig CEO Kenneth L. Londoner to Present at the 33rd Annual Virtual ROTH Conference · Persbericht

4 maart 2021 · BioSig Awarded U.S. Patent Claims for its NeuroClear™ Subsidiary · Persbericht

16 februari 2021 · BioSig Appoints Brenda Castrodad to Lead Human Resources · Persbericht

11 februari 2021 · Global Cardiovascular Devices Market Now Project to Exceed $71 Billion By 2027 · Persbericht

10 februari 2021 · Major Medical Centers Enter into Installation Agreements for Evaluation of BioSig PURE EP™ Systems · Persbericht

8 februari 2021 · Small and Microcap Company Investor Presentations Now Available for On-Demand Viewing · Persbericht

28 januari 2021 · Live Investor Conference & Webinar: Small and Microcap Company Showcase on February 4th · Persbericht

27 januari 2021 · BioSig CEO Kenneth L. Londoner to Present at the Virtual Investor Conference Small and Microcap Showcase · Persbericht

15 januari 2021 · BioSig to Present at the 26th Annual International AF Symposium · Persbericht

14 januari 2021 · BioSig PURE EP System Featured in the Editorial of EP Lab Digest · Persbericht

13 januari 2021 · BioSig Deploys Vuzix M400 Smart Glasses to Offer Remote Servicing Capabilities in Compliance with COVID-19 Travel Restrictions · Persbericht

12 januari 2021 · BioSig Conducts First Patient Cases with PURE EP(tm) System at Memorial Hospital of South Bend, Indiana · Persbericht

6 januari 2021 · BioSig CEO Kenneth L. Londoner to Present at the Sidoti Winter 2021 Investor Conference · Persbericht

Mijn selecties